S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
3 Reasons This Sleeping Giant Is About To Wake Up
The single greatest medical breakthrough of all time? (Ad)
MarketBeat Week in Review – 9/18 - 9/22
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
The single greatest medical breakthrough of all time? (Ad)
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
The single greatest medical breakthrough of all time? (Ad)
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
Speaker McCarthy is giving hard-right Republicans what they want. But it never seems to be enough.
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
3 Reasons This Sleeping Giant Is About To Wake Up
The single greatest medical breakthrough of all time? (Ad)
MarketBeat Week in Review – 9/18 - 9/22
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
The single greatest medical breakthrough of all time? (Ad)
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
The single greatest medical breakthrough of all time? (Ad)
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
Speaker McCarthy is giving hard-right Republicans what they want. But it never seems to be enough.
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
3 Reasons This Sleeping Giant Is About To Wake Up
The single greatest medical breakthrough of all time? (Ad)
MarketBeat Week in Review – 9/18 - 9/22
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
The single greatest medical breakthrough of all time? (Ad)
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
The single greatest medical breakthrough of all time? (Ad)
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
Speaker McCarthy is giving hard-right Republicans what they want. But it never seems to be enough.
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
3 Reasons This Sleeping Giant Is About To Wake Up
The single greatest medical breakthrough of all time? (Ad)
MarketBeat Week in Review – 9/18 - 9/22
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
The single greatest medical breakthrough of all time? (Ad)
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
The single greatest medical breakthrough of all time? (Ad)
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
Speaker McCarthy is giving hard-right Republicans what they want. But it never seems to be enough.
NASDAQ:PFHC

ProFrac (PFHC) Price Target & Analyst Ratings

$10.60
-0.21 (-1.94%)
(As of 09/22/2023 ET)
Compare
Today's Range
$10.55
$11.13
50-Day Range
$10.21
$12.87
52-Week Range
$13.18
$23.62
Volume
469,205 shs
Average Volume
431,097 shs
Market Capitalization
$1.51 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$30.00

ProFrac Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Buy
Based on 1 Analyst Ratings

Consensus Analyst Price Target

$30.00
183.02% Upside
High Prediction$30.00
Average Prediction$30.00
Low Prediction$30.00
TypeCurrent
9/24/22 to 9/24/23
1 Month Ago
8/25/22 to 8/25/23
3 Months Ago
6/26/22 to 6/26/23
1 Year Ago
9/24/21 to 9/24/22
Consensus Rating
Buy
Buy
Moderate Buy
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
1 Buy rating(s)
1 Buy rating(s)
1 Buy rating(s)
6 Buy rating(s)
Hold
0 Hold rating(s)
0 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$30.00$30.00$25.67$27.08
Predicted Upside183.02% Upside93.30% Upside60.74% Upside44.33% Upside
Get ProFrac Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for PFHC and its competitors with MarketBeat's FREE daily newsletter.


PFHC Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

PFHC Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

ProFrac Stock vs. The Competition

TypeProFracOils/Energy CompaniesS&P 500
Consensus Rating Score
3.00
2.56
2.49
Consensus RatingBuyModerate BuyHold
Predicted Upside183.02% Upside373.21% Upside629.68% Upside
News Sentiment RatingNeutral News
Positive News
Positive News

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
9/26/2022Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Connor Lynagh
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOverweight$28.00 ➝ $30.00+93.30%
(Data available from 9/24/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












PFHC Price Target - Frequently Asked Questions

What is ProFrac's consensus rating and price target?

According to the issued ratings of 1 analysts in the last year, the consensus rating for ProFrac stock is Buy based on the current 1 buy rating for PFHC. The average twelve-month price prediction for ProFrac is $30.00 with a high price target of $30.00 and a low price target of $30.00. Learn more on PFHC's analyst rating history.

Do Wall Street analysts like ProFrac more than its competitors?

Analysts like ProFrac more than other Oils/Energy companies. The consensus rating for ProFrac is Buy while the average consensus rating for oils/energy companies is Moderate Buy. Learn more on how PFHC compares to other companies.

Does ProFrac's stock price have much upside?

According to analysts, ProFrac's stock has a predicted upside of 93.30% based on their 12-month price targets.


Stock Ratings Reports and Tools

This page (NASDAQ:PFHC) was last updated on 9/24/2023 by MarketBeat.com Staff

My Account -